OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study

BACKGROUND: OnabotulinumtoxinA (OnabotA) is considered effective in in patients with chronic migraine (CM) who failed on traditional therapies. This study was designed to evaluate the effect of OnabotA injection series on migraine outcome, negative emotional states and sleep quality in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydinlar, Elif Ilgaz, Dikmen, Pinar Yalinay, Kosak, Seda, Kocaman, Ayse Sagduyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315653/
https://www.ncbi.nlm.nih.gov/pubmed/28213829
http://dx.doi.org/10.1186/s10194-017-0723-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315653/
https://www.ncbi.nlm.nih.gov/pubmed/28213829
http://dx.doi.org/10.1186/s10194-017-0723-4

Ejemplares similares